Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
暂无分享,去创建一个
R. Tibshirani | T. Hastie | D. Botstein | J. Matese | P. Brown | M. Eisen | C. Perou | S. Jeffrey | M. van de Rijn | T. Sørlie | T. Aas | S. Geisler | H. Johnsen | T. Thorsen | H. Quist | P. Lønning | A. Børresen-Dale
[1] Z. Hall. Cancer , 1906, The Hospital.
[2] D. Barnes,et al. The association of cytosol oestrogen and progesterone receptors with histological features of breast cancer and early recurrence of disease. , 1983, British Journal of Cancer.
[3] T. Lemarchand-Béraud,et al. The predictive value of estrogen and progesterone receptors' concentrations on the clinical behavior of breast cancer in women °clinical correlation on 547 patients , 1986, Cancer.
[4] S. Iacobelli,et al. Epidermal growth factor receptor in human breast cancer: correlation with steroid hormone receptors and axillary lymph node involvement. , 1988, European journal of cancer & clinical oncology.
[5] W Godolphin,et al. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. , 1989, Science.
[6] I. Ellis,et al. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. , 2002, Histopathology.
[7] M. Gerretsen,et al. A phase III randomised trial of cisplatinum, methotrextate, cisplatinum + methotrexate and cisplatinum + 5-FU in end stage squamous carcinoma of the head and neck. Liverpool Head and Neck Oncology Group. , 1990, British Journal of Cancer.
[8] C. Redmond,et al. Pathologic findings from the national surgical adjuvant breast project (protocol 4): Discriminants for 15‐year survival , 1993, Cancer.
[9] Genes, chromosomes & cancer , 1995 .
[10] E. Hovig,et al. TP53 mutations and breast cancer prognosis: Particularly poor survival rates for cases with mutations in the zinc‐binding domains , 1995, Genes, chromosomes & cancer.
[11] L. Holmberg,et al. Complete sequencing of the p53 gene provides prognostic information in breast cancer patients, particularly in relation to adjuvant systemic therapy and radiotherapy , 1995, Nature Medicine.
[12] T. Aas,et al. Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients , 1996, Nature Medicine.
[13] A. Lazaris,et al. PROGNOSTIC SIGNIFICANCE OF THE CO‐EXPRESSION OF p53 AND c‐erbB‐2 PROTEINS IN BREAST CANCER , 1996, The Journal of pathology.
[14] A. Ruíz,et al. Prognostic significance of c-erbB-2/neu amplification and epidermal growth factor receptor (EGFR) in primary breast cancer and their relation to estradiol receptor (ER) status. , 1997, Clinica chimica acta; international journal of clinical chemistry.
[15] D. Botstein,et al. Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[16] J. Varley,et al. Highly consistent genetic alterations in childhood adrenocortical tumours detected by comparative genomic hybridization , 1999, British Journal of Cancer.
[17] J. Mesirov,et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. , 1999, Science.
[18] Cathepsin-D in primary breast cancer: prognostic evaluation involving 2810 patients , 1999, British Journal of Cancer.
[19] R. Vossen,et al. Complete sequencing of TP53 predicts poor response to systemic therapy of advanced breast cancer. , 2000, Cancer research.
[20] Christian A. Rees,et al. Molecular portraits of human breast tumours , 2000, Nature.
[21] Ash A. Alizadeh,et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling , 2000, Nature.
[22] T. Aas,et al. Influence of TP53 gene alterations and c-erbB-2 expression on the response to treatment with doxorubicin in locally advanced breast cancer. , 2001, Cancer research.
[23] R. Tibshirani,et al. Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[24] E. Dougherty,et al. Gene-expression profiles in hereditary breast cancer. , 2001, The New England journal of medicine.